Fenugreek Seed Ethanolic Extract Improves Alveolar Bone Parameters by Attenuating Inflammation in Ovariectomized Rats

Abstract

Introduction

Alveolar bone residual ridge resorption remains a major challenge for dental implant placement in patients with edentulism. Fenugreek seed extracts have been reported to have potential roles in bone metabolism.

Purpose

This study aimed to evaluate the effects of fenugreek seed ethanolic extract (FSEE) on bone cells, inflammation, hormones, and angiogenesis parameters of alveolar bone tissue following teeth extraction in an ovariectomized (OVX) model.

Methods

A total of 30 adults female Wistar rats were assigned into two major groups. Each group consisted of control, OVX, OVX+FSEE 100 mg/kg BW, OVX+FSEE 200 mg/kg BW, and OVX+FSEE 400 mg/kg BW. The FSEE treatment was applied through the intragastric route for 7 days in the first group and for 30 days in the second group of animals. The first molar tooth of the right maxilla was extracted before the FSEE treatment. The level of 17β-estradiol was measured by the ELISA method. The dissected maxilla alveolar bone processus was sectioned for histological evaluation by hematoxylin–eosin staining and an immunohistochemistry assay.

Results

This study found that FSEE reduced the blood estrogen level and increased estrogen receptor-α (ER-α) expression. FSEE administration modified the number of bone cells, angiogenesis, vascular endothelial growth factor (VEGF), sclerostin, and the osteoprotegerin/receptor activator of nuclear factor kappa-β ligand (OPG/RANKL) ratio. Alterations were seen in the inflammatory markers interleukin-6 (IL-6), transforming growth factor-β₁ (TGF-β₁), and the macrophage-1/macrophage-2 (M1/M2) ratio.

Conclusion

In this study, inflammation was found to be attenuated by reductions in IL-6 and sclerostin, and an increase in TGF-β₁. The maturation of bone osteocytes increased along with the increase in ER-α expression and ratio of OPG/RANKL.

Keywords:

• angiogenesis
• antioxidant
• edentulism
• estrogen
• osteoblast

Introduction

Edentulism is defined as the permanent loss of natural teeth in the oral cavity. Both partial and complete edentulism can reduce a person’s quality of life because adequate teeth are required for mastication processes, speech, and aesthetic value. A higher prevalence of edentulism is reported among elderly people and in populations of developing countries. Since the incidence of edentulism is correlated with poor socioeconomic factors, edentulism is of concern as a global public health issue.^1,2

Dental implants may be proposed as a way to maintain the dental function of edentulous individuals. Conventional dental implant placement requires the presence of a proper alveolar residual ridge. Alveolar residual ridge disposition may present a challenge for dental implant procedures.³ Alveolar residual ridge resorption results from bone remodeling after teeth extraction. Resorption involves osteoclast activities that induce structural bone loss of the alveolar bone.^4,5

Estrogen deficiency, immune activation, and oxidative stress may be involved in the biomechanism of residual ridge resorption.^4,6 Inflammation initiates interactions between T cells and osteoclasts. This interaction leads to T-cell activation, which increases the release of receptor activator of nuclear factor kappa-Β ligand (RANKL) and the cytokines tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6). Inflammation promotes osteoclast activity in bone resorption.⁴ Chronic inflammatory processes lead to an imbalance between free radicals and antioxidant enzymes, resulting in oxidative stress conditions.⁷ Osteoclast activity is influenced by the state of hormones, especially estrogen. A hypoestrogenic state induces a decline in bone volume, bone density, and bone mineral density.⁸ These biomechanisms indicate the importance of treatment to inhibit residual ridge resorption.

Fenugreek (Trigonella foenum-gaecum) is widely known as a folk medicine. It acts as a galactagogue by increasingthe prolactin level.⁹ Bioactive compounds of fenugreek seed have been proposed as potential treatments for hyperglycemia and hypercholesterolemia, and as antimicrobials, antioxidants, etc.¹⁰ Studies on the phytoestrogenic roles of fenugreek seed in an ovariectomized model found that it improves brain-derived neurotrophic factor, memory, and cognitive performance.^11,12 The binding affinity of fenugreek compound to the estrogen receptor is stronger than that of other phytoestrogenic plants.¹³ The anti-inflammatory effects of fenugreek seed have been demonstrated in ovariectomized rats supplemented with a high-fat diet.¹⁴ The estrogenic potential of FSEE has been reported to be superior to that of fenugreek aqueous extract in improving the weight of reproductive organs and tissue in ovariectomized mice.¹⁵ To the authors’ knowledge, limited information is available on the effects of FSEE on bone parameters in the ovariectomized model. Because of the importance of optimal residual ridge in cases of edentulism, and the strong potential for the phytoestrogenic role of FSEE, further exploration is necessary to overcome edentulism. Thus, this study aimed to evaluate the effect of FSEE in inhibiting alveolar bone residual ridge resorption in ovariectomized rats, focusing on estrogen, bone cells, inflammation, and angiogenesis parameters.

Materials and Methods

Plant Materials and Extraction

Fenugreek seeds were obtained from Materia Medika Herbal Laboratories, owned by the East-Java Province Government (Malang, East Java, Indonesia). The air-dried (28±2°C) seeds were powdered before being extracted by maceration. The powder was macerated in 96% ethanol solvent (5 mL/g) for 72 hours at 37°C. The filtrate was evaporated using a rotary vacuum evaporator at 50°C.¹⁶ The extracts were kept at 4°C before being applied to the animals.¹⁷

Experimental Design

Animals were randomly assigned into two groups of 15. Each group consisted of subgroups, namely, sham surgery as the control, ovariectomized (OVX), OVX+fenugreek 100 mg/kg BW, OVX+fenugreek 200 mg/kg BW, and OVX+fenugreek 400 mg/kg BW. Each subgroup consisted of three animals. The first and second groups of animals differed in the duration of fenugreek treatment, ie, 7 and 30 days, respectively (Figure 1). Thirty days post-ovariectomy, the animals underwent tooth extraction followed by FSEE administration. The extracts were diluted in distillate water to a volume of 1 mL before being administered to the animals. The extract was applied in a single daily dose via the intragastric route.¹⁸

Figure 1 Effect of FSEE on blood estrogen (A), ER-α expression (B), osteoblasts (C), osteoclasts (D), osteocytes (E), and ratio of OPG/RANKL (F). Data are shown as mean ± SEM. *p<0.05, **p<0.001, ***p<0.0002, ****p<0.0001.

Abbreviations: FSEE, fenugreek seed ethanolic extract; OVX, ovariectomized; ERα, estrogen receptor-α; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor kappa-β ligand.

Animals

All animal procedures followed the guidelines of the National Center for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), and were approved in advance by the Health Research Ethic Committee of the Faculty of Medicine, Universitas Brawijaya (no 173/EC/KEPK/06/2022). Female adult Wistar rats, aged 4–6 months, were obtained from Institut Teknologi Bandung (Bandung, West Java, Indonesia). The animals were maintained in a room with controlled temperature and humidity, and a 12–12-hour light–dark cycle. Standard laboratory food and drink were provided ad libitum.¹⁹

Ovariectomy Surgery

Ovariectomy procedures were performed under sterile conditions. Animals were anesthetized with ketamine–xylazine via intraperitoneal injection. A single ventral transverse skin incision was carried out to expose the ovaries. Ovaries were ligated and severed using 2/0 silk string. After fat-pad repositioning, muscle-pad skin was sutured in two layers. The sham control animals received a similar incision without removal of the ovaries.^20,21

Extraction of Teeth

The teeth were extracted following a modified version of previous protocols. In brief, the animals were sedated and anesthetized using ketamine–xylazine, injected intraperitoneally. Preoperatively, the area surrounding the first molar right maxilla was cleaned using iodine solution. The teeth were completely extracted using sterile forceps. The socket was gently irrigated using saline liquid. Animals were placed individually until complete recuperation from the anesthesia (approximately 24 hours), with water provided ad libitum, followed by regular feeding on the next day.^22,23

Collection of Blood Samples and Enzyme-Linked Immunosorbent Assay (ELISA)

Blood was collected under anesthesia via intracardiac puncture. After incubation at room temperature, the clotted blood samples were centrifuged at 3500 rpm for 10 minutes. The supernatants were collected and refrigerated at −20°C until further analysis. The level of 17β-estradiol was measured using a commercial ELISA kit, ie, Rat 17β-estradiol (BT Laboratory, catalogue no E1393Ra). The assay was performed according to the manufacturer’s protocols.²⁴

Tissue Collection and Immunohistochemistry Assay

Dissected bone alveolar processes of the maxilla were fixated in 4% paraformaldehyde overnight at 4°C. After washing in phosphate-buffered saline (PBS), the tissues were decalcified in 10% ethylenediaminetetraacetic acid (EDTA) for 2–4 weeks. The tissue was then dehydrated and embedded in paraffin using standard histological procedures. Then, 5‑µm sections were prepared for hematoxylin and eosin (H&E) staining and immunohistochemical analysis. Deparaffinized sections were immersed in citrate buffer for antigen retrieval. After washing in PBS, the sections were blocked in 3% hydrogen peroxide followed by primary and secondary antibody incubation, and stained with diaminobenzidine buffer as the chromogen.²⁵ The antibodies used for this study were: sclerostin polyclonal antibody (Thermo Fisher Scientific, catalogue no PA5-37943); interleukin-6 (IL-6) antibody (C12-1-hIL-6; Santa Cruz Biotechnology, catalogue no sc-32296); vascular endothelial growth factor (VEGF) expression was analyzed using anti-VEGFA antibody (VG-1) (Abcam, catalogue no ab1316); receptor activator of nuclear factor-κβ ligand (RANKL) was analyzed using RANKL antibody (12A668) (Santa Cruz Biotechnology, catalogue no sc-52950); osteoprotegerin (OPG) was analyzed using osteoprotegerin antibody (E-10) (Santa Cruz Biotechnology, catalogue no sc-377079); transforming growth factorβ₁ (TGF-β₁) was analyzed using TGF-β₁ polyclonal antibody (Elabscience, catalogue no E-AB-33090); macrophage-1 (M1) and macrophage-1 (M2) were analyzed using anti-CD163 and anti-CD163 rabbit monoclonal antibody (Boster Bio, catalogue no M00812).

Statistical Analysis

Data are shown as mean ± SEM. Statistical analysis was carried out using two-way ANOVA to analyze the mean differences between groups, in GraphPad Prism 9.0.0. The significance value was set at p<0.05.¹⁷

Results

The level of blood estrogen (17β-estradiol) in the ovariectomized group (257.09±143.38 ng/L) increased by 13% compared to the control group (225.75±160.69 ng/L) after 7 days of follow-up. The increment of blood estrogen dramatically increased (75.06%) at 30 days post-ovariectomy. FSEE at a dose of 100 mg/kg BW had the greatest effect on reducing the blood estrogen level, in both 7 days (65.86±23.68 ng/L) and 30 days (139±3.56 ng/L). Higher doses of FSEE resulted in an increase in blood estrogen levels (Figure 1A).

Alveolar bone tissue among rats in the ovariectomized group showed a lower expression of ER-α than in the control group (2.67±0.58 vs 5.67±0.58 ER-α-positive cells) at 7 days. At the longer follow-up (30 days), a greater reduction (54.17%) in ER-α was seen. FSEE increased the expression of ER-α in a dose-dependent manner, ie, 5±1, 7.33±1.25, and 8±1 ER-α-positive cells for doses of 100, 200, and 400 mg/kg BW, respectively, at 7 days. A similar escalation was demonstrated after 30 days of treatment (Figure 1B).

The number of osteoblasts in alveolar bone tissue after 7 days of treatment was 12.53±1.27, 19.13±3.16, 13.83±2.23, and 13.20±4.85 for ovariectomized, and FSEE doses of 100, 200, and 400 mg/kg BW, respectively. Lower numbers of osteoblasts were observed after 30 days of treatment, ie, 7.17±2.19, 9.13±0.42, 7.23±1.09, and 6.37±0.66 for the respective groups (Figure 1C). In contrast, the numbers of osteoclasts were lower in the ovariectomized group at both 7 and 30 days compared to controls. The increase in osteoclasts was more prominent after 30 days’ administration of FSEE (Figure 1D). The number of osteocytes in ovariectomized mice was not different from those of controls at 7 days, whereas at 30 days, the number of osteocytes decreased in the ovariectomized group (9.97±2.29) compared to controls (14.73±1.12). FSEE increased the number of osteocytes significantly at 30 days of treatment (Figure 1E). Meanwhile, the ratio of OPG/RANKL was drastically reduced in ovariectomized rats (Figure 1F).

FSEE administration did not significantly affect the number of tissue blood vessels in the alveolar bone tissue at 7 days of treatment. The dose of 400 mg/kg BW increased the number of blood vessels significantly compared to 100 and 200 mg/kg BW doses at 30 days of treatment (Figure 2A). Conversely, the number of VEGF-positive cells significantly increased in the FSEE-treated groups at 7 and 30 days of treatment (Figure 2B). The inflammatory cytokine IL-6 sharply increased after ovariectomy. IL-6 significantly reduced after FSEE treatment, with the lowest IL-6 level being observed with the highest dose application (Figure 2C). In contrast, TGF-β₁ (Figure 2D) and the ratio of M1/M2 decreased after ovariectomy (Figure 2F). Treatment with FSEE increased the level of TGF-β₁, the ratio of OPG/RANKL, and the ratio of M1/M2 macrophages. The highest dose of FSEE reduced the expression of sclerostin by about 61.54% and 75.75% compared to the ovariectomized group at 7 days and 30 days, respectively (Figure 2E). The histological and immunohistochemistry staining of alveolar bone tissue sections is shown in Figure 3.

Figure 2 Effect of FSEE on number of blood vessels (A), VEGF expression (B), IL-6 expression (C), TGF-β₁ expression (D), sclerostin expression (E), and ratio of M1/M2 (F). Data are shown as mean ± SEM. *p<0.05, **p<0.001, ***p<0.0002, ****p<0.0001.

Abbreviations: FSEE, fenugreek seed ethanolic extract; VEGF, vascular endothelial growth factor; IL-6, interleukin-6; TGF-β₁, transforming growth factor-β₁; M1/M2, macrophage-1/macrophage-2 ratio; Ovx, ovariectomized.

Figure 3 Hematoxylin–eosin staining and immunohistochemical analysis of alveolar tissue sections after different durations of FSEE treatment.

Abbreviations: FSEE, fenugreek seed ethanolic extract; OVX, ovariectomized; HE, hematoxylin–eosin; ERα, estrogen receptor-α; VEGF, vascular endothelial growth factor; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor kappa-β ligand; IL-6, interleukin-6; TGF-β₁, transforming growth factor-β₁.

Discussion

Most previous studies have confirmed a decline in estrogen levels after ovariectomy in rats.^26,27 In the present study, a rise in the blood estrogen level was shown following ovariectomy surgery. Extragonadal aromatization by peripheral tissues has been suggested as a basic mechanism of the escalation in circulatory estrogen post-ovariectomy. Liver, adrenal, and adipose tissue produce P450 aromatase protein, which is closely related to peripheral estrogen conversion in ovariectomized rats.²⁸

Estrogen is essential for angiogenesis, a process that promotes neovascularization. This effect is mediated through the activation of ER-α and VEGF stimulation.²⁹ Intriguingly, this study showed that blood vessel augmentation is not linked to the rise in VEGF among ovariectomized rats. Despite VEGF stimulation, vascular remodeling can be mediated by the activation of G-protein estrogen receptor (GPER). This receptor modulates the differentiation of endothelial cells via both direct and indirect stimulation.³⁰ Estrogen signaling through ER-α inhibits osteoblast and osteocyte apoptosis, as well as attenuating osteoclast activity, thereby decreasing bone resorption.³¹ The decline in ER-α in this study may explain the finding of alveolar bone osteoblast, osteoclast, and osteocyte reduction in ovariectomized rats, even as the circulatory estrogen increased.

This study showed that ovariectomy induced IL-6 and reduced TGF-β₁ cytokines. The overexpression of IL-6 is linked to the inflammation process.³² Oral inflammation stimulates the release of sclerostin as a bone turnover marker, thereby increasing the activity of osteoclasts.³³ The cytokine IL-6 also plays a role as a stimulus for extragonadal aromatization is IL-6 cytokine via activation of CYP19 promoter with glucocorticoid costimulator.³⁴ Hyperestrogen stimulates the generation of reactive oxygen species (ROS) as a marker of early oxidative stress under pathological conditions.³⁵ Oxidative stress presents low antioxidant enzymes and high MDA level reported in edentulous subjects with residual ridge resorption. Both inflammation and oxidative stress were established as molecular pathway of residual ridge resorption.^7,36

Fenugreek inhibited inflammation through the reduction of IL-6, as proposed in an earlier study.³⁷ The polarization of macrophages is influenced by fenugreek methanolic extract (FME). M1-type marker cytokines, such as TNF-α and IL-6, were reduced following FME treatment. On the other hand, gene markers for M2 increased significantly after FME.³⁸ The M2 macrophage is a proangiogenic phenotype which plays a role in the expression of VEGF.³⁹ This is supported by a study which found that consuming fenugreek also enhanced the expression of VEGF in people with coronary artery disease; however, this effect was obtained from 8 weeks of fenugreek extract administration.⁴⁰

The role of fenugreek in estrogen hormone regulation remain inconclusive, depending on the particular case. The reduction of estrogen was reported in a hyperstimulation rat model, with decreases in follicle-stimulating hormone (FSH) and luteinizing hormone (LH). Conversely, FSH stimulation was observed after the administration of fenugreek to subjects with polycystic ovary syndrome.⁴¹ The current findings concurred with non-significant results following fenugreek extract administration on serum estradiol, bone resorption, and bone formation markers.¹⁸ However, another report revealed that a similar species of Trigonella induced the maturation of osteoblasts through extracellular calcium concentrations.⁴² Further explanation for the effect of our FSEE in inhibiting alveolar bone residual ridge resorption may be associated with the antioxidant properties of fenugreek. The scavenger activities of fenugreek have been identified as coming from its seed oils, namely, palmitic acid and linoleic acid.⁴³ A previous study revealed the role of fenugreek seed extract in the combination of ovariectomy and metabolic disorder via treatment with a high-fat diet. The role of fenugreek as an inhibitor of cholesterol, inflammation, and histopathological changes in cholesterol-associated tissue has been well elucidated.¹⁴ Further exploration is necessary to describe the molecular mechanisms through which fenugreek extract inhibits residual ridge resorption in the ovariectomy model, as well as the metabolic profiles.

Conclusion

FSEE reduced the levels of 17β-estradiol, IL-6, and sclerostin. In contrast, FSEE increased ER-α expression, osteocyte maturation, and TGF-β₁ expression.

Disclosure

The authors report no conflicts of interest in this work.

Acknowledgments

The authors would like to thank the Faculty of Medicine, Universitas Brawijaya, for the use of laboratory facilities.